Treatment of early bulky cervical cancer with neoadjuvant paclitaxel, carboplatin and cisplatin prior to laparoscopical radical hysterectomy and pelvic lymphadenectomy

Oncology Letters

Volumn 3, Issue 3, 2012, Pages 641-645

  Shen, Yi ^a   Yang, Lu ^a   Wang, Zehua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Cervical cancer; Neoadjuvant chemotherapy; Paclitaxel

Indexed keywords

CARBOPLATIN; CISPLATIN; PACLITAXEL;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BULKY CERVICAL CANCER; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SIZE; CANCER SURGERY; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GRANULOCYTE; HUMAN; LAPAROSCOPIC SURGERY; LEUKOCYTE COUNT; LIVER INJURY; LYMPH NODE METASTASIS; METASTASIS; NAUSEA AND VOMITING; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; RADICAL HYSTERECTOMY; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT RESPONSE; UTERINE CERVIX CANCER;

EID: 84862938892     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.529     Document Type: Article

References (18)

1. Eddy GL, Bundy BN, Creasman WT, et al: Treatment of ('bulky') stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group. Gynecol Oncol 106: 362-369, 2007.
2. Benedetti Panici P, Greggi S, Scambia G, et al: Long-term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Eur J Cancer 34: 341-346, 1998.
3. Choi CH, Kim T, Lee J, et al: Phase II study of neoadjuvant chemotherapy with mitomycin-c, vincristine and cisplatin (MVC) in patients with stages IB2-IIB cervical cancer. Gynecol Oncol 104: 64-69, 2007.
4. Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer Meta-analysis Collaboration: Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials. Eur J Cancer 39: 2470-2486, 2003.
5. Bae JH, Lee S, Lee A, et al: Neoadjuvant cisplatin and etoposide followed by radical hysterectomy for stage 1B-2B cervical cancer. Gynecol Oncol 111: 444-448, 2008.
6. Lihong Zhu, Lihui Wei, Xiaoping Li, et al: Killing effect of paclitaxel liposome on cervical carcinoma SiHa cells in vitro. Bull. Chin Cancer 17: 704-707, 2008.
7. Shen Y and Wang Z: Total laparoscopic radical hysterectomy for treatment of uterine malignant tumors: analysis of short-term therapeutic efficacy. J Huazhong Univ Sci Technol [Med Sci] 30: 376-379, 2010.
8. Lai CH, Hsueh S, Chang TC, et al: Prognostic factors in patients with bulky stage IB or IIA cervical carcinoma undergoing neoadjuvant chemotherapy and radical hysterectomy. Gynecol Oncol 64: 456-462, 1997.
9. Katsumata N, Yoshikawa H, Hirakawa T, et al: Phase III randomized trial of neoadjuvant chemotherapy (NAC) followed by radical hysterectomy (RH) versus RH for bulky stage I/II cervical cancer. ASCO Annu Meet Proc 24: abs. 5013, 2006.
10. Monk B, Huang HQ, Cella D, et al: Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group Study. J Clin Oncol 23: 4617-4625, 2005.
11. Buda A, Fossati R, Colombo N, et al: Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study. J Clin Oncol 23: 4137-4145, 2005.
12. Moore DH, Blessing JA, McQuellon MP, et al: Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 22: 3113-3119, 2004.
13. Park DC, Kim JH, Lew YO, Kim DH and Namkoong SE: Phase II trial of neoadjuvant paclitaxel and cisplatin in uterine cervical cancer. Gynecol Oncol 92: 59-63, 2004.
14. Dueñas-Gonzalez A, López-Graniel C, González-Enciso A, et al: A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation. Ann Oncol 14: 1278-1284, 2003.
15. D'Agostino G, Distefano M, Greggi S, et al: Neoadjuvant treatment of locally advanced carcinoma of the uterine cervix with epirubicin, paclitaxel and cisplatin. Cancer Chemother Pharmacol 49: 256-260, 2004.
16. Zanetta G, Lissoni A, Pellegrino A, et al: Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer. Ann Oncol 9: 977-980, 1998.
17. Hwang YY, Moon H, Cho SH, et al: Ten-year survival of patients with locally advanced stage IB-IIB cervical cancer after neoadjuvant chemotherapy and radical hysterectomy. Gynecol Oncol 82: 88-93, 2001.
18. Eddy GL, Manetta A, Alvarez RD, et al: Neoadjuvant chemotherapy with Vincristin and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a gynecologic oncology group pilot study. Gynecol Oncol 57: 412-416, 1995.